US 12,076,358 B2
Composition of desmodium and trivalent chromium, and ocular use
Sophie Hvostoff, Mennecy (FR); and Rima Yazbeck, Ramonville Saint Agne (FR)
Assigned to LABORATOIRES THEA, Clermont-Ferrand (FR)
Appl. No. 17/593,239
Filed by Laboratoires THEA, Clermont-Ferrand (FR)
PCT Filed Mar. 23, 2020, PCT No. PCT/IB2020/052694
§ 371(c)(1), (2) Date Sep. 13, 2021,
PCT Pub. No. WO2020/194166, PCT Pub. Date Oct. 1, 2020.
Claims priority of application No. 1903045 (FR), filed on Mar. 25, 2019.
Prior Publication US 2022/0152140 A1, May 19, 2022
Int. Cl. A61K 36/48 (2006.01); A61K 33/24 (2019.01); A61K 45/06 (2006.01); A61P 27/02 (2006.01)
CPC A61K 36/48 (2013.01) [A61K 33/24 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01)] 21 Claims
 
1. A composition consisting of:
a powder of Desmodium adscendens or Desmodium gangeticum; and
a trivalent chromium salt.